Product Benefits

• Dual-Action Pressure Reduction: Combines two active ingredients (Brinzolamide and Timolol) that lower intraocular pressure (IOP) through different physiological pathways for a more powerful effect than single-drug therapy.

• Suppresses Fluid Production: Brinzolamide, a carbonic anhydrase inhibitor, works by slowing the formation of bicarbonate ions, which directly decreases the secretion of aqueous humor (eye fluid).

• Enhanced Fluid Outflow: Timolol, a non-selective beta-blocker, reduces fluid production and slightly improves the eye's ability to drain fluid, further decreasing internal eye pressure.

• Vision Preservation: By consistently maintaining healthy IOP levels, it helps protect the optic nerve from damage, which is the primary cause of permanent vision loss in glaucoma patients.

• Synergistic Efficacy: Indicated specifically for patients who do not achieve sufficient pressure reduction with monotherapy (using only one type of eye drop).

• Sterile OSD Technology: Packaged in a specialized "Ophthalmic Squeeze Dispenser" (OSD) designed to keep the suspension sterile throughout its use by preventing air and contaminant entry.

• Long-Lasting Stability: The suspension formulation is designed to provide sustained contact with the eye surface, ensuring the active medication is absorbed effectively into the ocular tissues.

• Improved Compliance: Because it combines two medications into one bottle, it reduces the number of drops required daily, making it easier for patients to follow their treatment plan.

Dosage & Administration

• Adults: The recommended dose is 1 drop in the affected eye(s) twice daily.

• Instruction: Shake well before use. Wash hands, tilt head back, and instill the drop into the conjunctival sac.

• Pro-Tip: Apply gentle pressure to the tear duct (the corner of the eye near the nose) for about 1 minute after instilling the drop to minimize systemic absorption into the bloodstream.

Medical Disclaimer: Xolamid T OSD is a prescription medication. It is contraindicated in patients with a history of asthma, severe COPD, or certain heart conditions (like sinus bradycardia or heart block) due to the Timolol component. Remove contact lenses before use and wait at least 15 minutes before reinserting. Discard the bottle 4 weeks after first opening.